Biodexa Pharmaceuticals (BDRX) Interest Income - Net (2015 - 2022)

Biodexa Pharmaceuticals has reported Interest Income - Net for 4 years, with the latest figure at -$101674.7 in Q4 2020.

• Quarterly Interest Income - Net fell 182.37% year-over-year to -$101674.7 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was -$2.2 million (changed N/A YoY) and the FY2025 annual result came in at -$2.8 million, up 37.61% from the prior year.
• Interest Income - Net grew to -$101674.7 in Q4 2020 per BDRX's latest filing, from -$612010.3 in the prior quarter.
• Over five years, Interest Income - Net peaked at $123429.6 in Q4 2019 and troughed at -$1.6 million in Q4 2016.
• A 3-year average of -$540422.1 and a median of -$356842.5 in 2020 frame the typical range for Interest Income - Net.
• The sharpest annual moves came in 2016 and 2020: Interest Income - Net jumped 38.58% in 2016, then sank 182.37% in 2020.
• Over 3 years, Interest Income - Net stood at -$1.6 million in 2016, then surged by 107.85% to $123429.6 in 2019, then tumbled by 182.37% to -$101674.7 in 2020.
• According to Business Quant data, Interest Income - Net over the past three periods registered -$101674.7, -$612010.3, and $123429.6 for Q4 2020, Q3 2020, and Q4 2019 respectively.